GENEVA (Reuters) – The World Health Organization expects there will be no reason to change its assessment that the benefits of the AstraZeneca vaccine against COVID-19 outweigh any risks, a regulatory official told a news conference on Tuesday.
The WHO is closely studying the latest data alongside European and other regulators, in light of reports of blood clots among people who have been vaccinated, said Rogerio Gaspar, WHO director of regulation and prequalification.
He said the WHO expects to reach a fresh assessment on Wednesday or Thursday, but does not believe there will be a reason to change its advice that the benefits outweigh any risks.
(Reporting by John Miller and Stephanie Nebehay; Writing by Peter Graff; Editing by Kevin Liffey)
